title: [Current therapy of multiple sclerosis].
abstract: There is no cure for multiple sclerosis (MS). Many therapeutic strategies are known. With exception of high dose corticosteroids for the treatment of acute exacerbations most of the concepts are not generally accepted. Reasons are the variable, often unpredictable natural course of MS, the incomplete understanding of the pathophysiology and the difficult trial design. Yet, new therapeutic agents give hope at least to slow the course of the disease.
authors.affiliation: Universitätsklinik für Neurologie, Wien. Karl.Vass@AKH-Wien.ac.at
authors.forename: K
authors.initials: K
authors.lastname: Vass
authors.forename: M
authors.initials: M
authors.lastname: Schmied
mesh_terms: D001379:Azathioprine / Q000008:administration & dosage; D017338:Cladribine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D000068717:Glatiramer Acetate; D006801:Humans; D016899:Interferon-beta / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D008942:Mitoxantrone / Q000008:administration & dosage; D009103:Multiple Sclerosis / Q000628:therapy*; D010455:Peptides / Q000008:administration & dosage; D010956:Plasmapheresis; D016032:Randomized Controlled Trials as Topic
chemical_list: D010455:Peptides; D017338:Cladribine; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D003520:Cyclophosphamide; D008942:Mitoxantrone; D001379:Azathioprine; D008727:Methotrexate
vernacular_title: Aktuelle Therapie der Multiplen Sklerose.